Form 4: U.S. Physical Therapy Director Edward Kuntz Sells Shares

Director Edward Kuntz of U.S. Physical Therapy Inc. reports selling 2,500 shares of common stock at an average price of $104.26 on March 4, 2024.

Summary

• On March 4, 2024, Edward Kuntz, a director of U.S. Physical Therapy Inc., sold 2,500 shares of the company's common stock.
• The sale was executed at a weighted average price of $104.26 per share, with individual transactions ranging from $104.00 to $104.80.
• Following the transaction, Kuntz directly owns 5,780 shares, including 400 restricted shares that will vest on April 1, 2024, if he remains a director.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a director selling shares. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This is a routine disclosure of insider trading activity. It is important to monitor insider transactions as they can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates